These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 2479462)

  • 1. Susceptibility of EBV-carrying B cell lines to infection by HIV-1: variability of production of progeny virus and expression of viral antigens.
    Tremblay M; Wainberg MA
    Cancer Lett; 1989 Nov; 48(2):95-103. PubMed ID: 2479462
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heterogeneity of HIV-1 replication and antigen expression in EBV-transformed B cell lines.
    Tremblay M; Fitz-Gibbon L; Wainberg MA
    Leukemia; 1988 Dec; 2(12 Suppl):233S-240S. PubMed ID: 2849000
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Altered HIV expression and EBV-induced transformation in coinfected PBLs and PBL subpopulations.
    Henderson EE; Yang JY; Zhang RD; Bealer M
    Virology; 1991 May; 182(1):186-98. PubMed ID: 1708929
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Infection of Epstein-Barr virus-transformed lymphoblastoid B cells by the human immunodeficiency virus: evidence for a persistent and productive infection leading to B cell phenotypic changes.
    De Rossi A; Roncella S; Calabro ML; D'Andrea E; Pasti M; Panozzo M; Mammano F; Ferrarini M; Chieco-Bianchi L
    Eur J Immunol; 1990 Sep; 20(9):2041-9. PubMed ID: 2170147
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Susceptibility to AZT of HIV-1 variants grown in Epstein-Barr virus-transformed B cell lines.
    Tremblay M; Wainberg MA
    J Infect Dis; 1989 Jul; 160(1):31-6. PubMed ID: 2543710
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitation of HIV-1 activity in tissue culture supernatants: effects of culture condition on syncytial assays and virus production.
    Spickett G; Beattie RE; Bountiff L; Dalgleish AG; Webster AD
    J Virol Methods; 1989; 24(1-2):67-76. PubMed ID: 2474561
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Susceptibility of human monoclonal antibody-producing B cell lines to infection by human immunodeficiency virus.
    Shepherd AJ; Boyd JE; Hogg CL; Aw D; James K
    Hum Antibodies Hybridomas; 1992 Oct; 3(4):168-76. PubMed ID: 1335786
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Persistent productive HIV infection in EBV-transformed B lymphocytes.
    Tozzi V; Britton S; Ehrnst A; Lenkei R; Strannegård O
    J Med Virol; 1989 Jan; 27(1):19-24. PubMed ID: 2537875
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Morphological and phenotypical changes in EBV positive lymphoblastoid cells infected by HIV-1.
    De Rossi A; Calabro ML; D'Andrea E; Panozzo M; Saggiori D; Mammano F; Roncella S; Ferrarini M; Chieco-Bianchi L
    Leukemia; 1992; 6 Suppl 3():38S-40S. PubMed ID: 1318475
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human immunodeficiency virus (HIV) type 1 can superinfect HIV-2-infected cells: pseudotype virions produced with expanded cellular host range.
    Le Guern M; Levy JA
    Proc Natl Acad Sci U S A; 1992 Jan; 89(1):363-7. PubMed ID: 1346069
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contribution of multiple rounds of viral entry and reverse transcription to expression of human immunodeficiency virus type 1. A quantitative kinetic study.
    Pellegrino MG; Li G; Potash MJ; Volsky DJ
    J Biol Chem; 1991 Jan; 266(3):1783-8. PubMed ID: 1703155
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential human immunodeficiency virus expression in CD4+ cloned lymphocytes: from viral latency to replication.
    Chapel A; Bensussan A; Vilmer E; Dormont D
    J Virol; 1992 Jun; 66(6):3966-70. PubMed ID: 1374814
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lack of pseudotype formation between human immunodeficiency virus type 1 and Epstein-Barr virus in productively coinfected B lymphoblastoid cell lines.
    Van Kuyk R; Mosier DE
    Virology; 1995 Jun; 209(2):643-8. PubMed ID: 7778296
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Production of HIV-1 by human B cells infected in vitro: characterization of an EBV genome-negative B cell line chronically synthetizing a low level of HIV-1 after infection.
    Fritsch L; Marechal V; Schneider V; Barthet C; Rozenbaum W; Moisan-Coppey M; Coppey J; Nicolas JC
    Virology; 1998 May; 244(2):542-51. PubMed ID: 9601522
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synergy between human immunodeficiency virus type 1 and Epstein-Barr virus in T lymphoblastoid cell lines.
    Zhang RD; Guan M; Park Y; Tawadros R; Yang JY; Gold B; Wu B; Henderson EE
    AIDS Res Hum Retroviruses; 1997 Jan; 13(2):161-71. PubMed ID: 9007201
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epstein-Barr virus recombinants from BC-1 and BC-2 can immortalize human primary B lymphocytes with different levels of efficiency and in the absence of coinfection by Kaposi's sarcoma-associated herpesvirus.
    Aguirre AJ; Robertson ES
    J Virol; 2000 Jan; 74(2):735-43. PubMed ID: 10623735
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HTLV-III infection of EBV-genome-positive B-lymphoid cells with or without detectable T4 antigens.
    Salahuddin SZ; Ablashi DV; Hunter EA; Gonda MA; Sturzenegger S; Markham PD; Gallo RC
    Int J Cancer; 1987 Feb; 39(2):198-202. PubMed ID: 3026971
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human immunodeficiency virus (HIV) and Epstein-Barr virus (EBV) antigens and genome in lymph nodes of HIV-positive patients affected by persistent generalized lymphadenopathy (PGL).
    Uccini S; Monardo F; Vitolo D; Faggioni A; Gradilone A; Aglianó AM; Manzari V; Ruco LP; Baroni CD
    Am J Clin Pathol; 1989 Dec; 92(6):729-35. PubMed ID: 2556016
    [TBL] [Abstract][Full Text] [Related]  

  • 19. AZT (zidovudine) may act postintegrationally to inhibit generation of HIV-1 progeny virus in chronically infected cells.
    Rooke R; Tremblay M; Wainberg MA
    Virology; 1990 May; 176(1):205-15. PubMed ID: 1691885
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complement receptor 2 mediates enhancement of human immunodeficiency virus 1 infection in Epstein-Barr virus-carrying B cells.
    Tremblay M; Meloche S; Sekaly RP; Wainberg MA
    J Exp Med; 1990 May; 171(5):1791-6. PubMed ID: 2159052
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.